NASDAQ:VRAY
Delisted
ViewRay Inc Stock News
$0.0250
+0 (+0%)
At Close: Nov 20, 2023
FORT MYERS, Fla.--(BUSINESS WIRE)--GenesisCare, one of the leading integrated cancer care providers in the United States, Australia, Spain, and the United Kingdom, will launch ViewRay's advanced MRIdi
Military University Hospital Prague Selects ViewRay's MRIdian® MRI-Guided Radiation Therapy System to Treat Cancer Patients
06:30am, Tuesday, 07'th Mar 2023
First and only MRIdian in the Czech Republic to bring advanced MRI-guided radiation therapy to the region DENVER , March 7, 2023 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced the Czech
Siteman Cancer Center at Washington University Treats 2,000th Patient with MRIdian® MRI-Guided Radiation Therapy
06:30am, Thursday, 02'nd Mar 2023
World's first MRIdian center at Barnes-Jewish Hospital continues to lead the way for advanced precision cancer therapy with MRI-guided radiation DENVER , March 2, 2023 /PRNewswire/ -- ViewRay, Inc. (N
ViewRay, Inc. (VRAY) Q4 2022 Earnings Call Transcript
08:42pm, Monday, 27'th Feb 2023
ViewRay, Inc. (NASDAQ:VRAY ) Q4 2022 Earnings Conference Call February 27, 2023 4:30 PM ET Company Participants Matt Harrison - Director of IR Scott Drake - President and CEO Bill Burke - CFO Conferen
ViewRay (VRAY) Reports Q4 Loss, Misses Revenue Estimates
07:34pm, Monday, 27'th Feb 2023
ViewRay (VRAY) delivered earnings and revenue surprises of 6.25% and 0.71%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
ViewRay: Sales, Order Momentum Ratcheting Higher
11:32pm, Sunday, 12'th Feb 2023
ViewRay has continued growth in order momentum. Its stock price has moved sideways into the new year, adding another attractive entry point.
ViewRay Announces Conference Call for Fourth Quarter 2022 Financial Results to be Held After Market on February 27, 2023
06:30am, Tuesday, 31'st Jan 2023
DENVER , Jan. 31, 2023 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today details relating to the release of fourth quarter 2022 financial results. ViewRay will hold a conference call to dis
ViewRay: Revise Thesis To Buy, Multiple Upside Targets In Place
09:25am, Thursday, 24'th Nov 2022
Revised FY22 revenue guidance with management more confident on the lower end of range. Backlog continues to grow, ending 26% higher to $350mm for the third quarter.
ViewRay® to Present at the Stifel 2022 Healthcare Conference
06:30am, Thursday, 10'th Nov 2022
DENVER , Nov. 10, 2022 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will present at the Stifel 2022 Healthcare Conference. Scott Drake, President and Chief Executive O
ViewRay, Inc. (VRAY) Q3 2022 Earnings Call Transcript
08:44pm, Tuesday, 01'st Nov 2022
ViewRay, Inc. (NASDAQ:VRAY ) Q3 2022 Results Conference Call November 1, 2022 5:00 PM ET Company Participants Matt Harrison - Director, IR Scott Drake - President & CEO Zach Stassen - CFO Dr. Paul Str
ViewRay (VRAY) Reports Q3 Loss, Tops Revenue Estimates
08:19pm, Tuesday, 01'st Nov 2022
ViewRay (VRAY) delivered earnings and revenue surprises of 0% and 4.02%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
ViewRay Announces Conference Call for Third Quarter 2022 Financial Results to be Held After Market on November 1, 2022
06:30am, Friday, 14'th Oct 2022
DENVER, Oct. 14, 2022 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today details relating to the release of third quarter 2022 financial results. ViewRay will hold a conference call to discu
ViewRay® to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
06:30am, Friday, 09'th Sep 2022
DENVER , Sept. 9, 2022 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will present at the Morgan Stanley 20th Annual Global Healthcare Conference.
ViewRay, Inc. (VRAY) CEO Scott Drake on Q2 2022 Results - Earnings Call Transcript
09:40pm, Tuesday, 02'nd Aug 2022
ViewRay, Inc. (NASDAQ:VRAY ) Q2 2022 Earnings Conference Call August 2, 2022 4:30 PM ET Company Participants Matt Harrison - Director, IR Scott Drake - President & CEO Zach Stassen - CFO Conference Ca
ViewRay (VRAY) Reports Q2 Loss, Tops Revenue Estimates
06:51pm, Tuesday, 02'nd Aug 2022
ViewRay (VRAY) delivered earnings and revenue surprises of 0% and 13.19%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
